Home/Filings/4/0001415889-24-004108
4//SEC Filing

Gravier Pierre 4

Accession 0001415889-24-004108

CIK 0001070081other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:11 PM ET

Size

9.1 KB

Accession

0001415889-24-004108

Insider Transaction Report

Form 4
Period: 2024-02-15
Gravier Pierre
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2024-02-15+3,10055,800 total
  • Award

    Common Stock

    2024-02-15+19,00052,700 total
  • Award

    Stock Option (Right to Buy)

    2024-02-15+47,50047,500 total
    Exercise: $25.69Exp: 2034-02-14Common Stock (47,500 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025.
  • [F2]Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025.
  • [F3]This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001984065

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:11 PM ET
Size
9.1 KB